Aurobindo Pharma has received final approval from the US Food and Drug Administration to manufacture and market Oxacillin injections.
Oxacillin injection is sterile semi-synthetic penicillin indicated in the treatment of infections caused by penicillinase producing staphylococci, which have demonstrated susceptibility to the drug.
The product is ready for the launch, the Hyderabad-based company informed the Bombay Stock Exchange on Monday.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.